Results
|
|
19941.
|
|
|
|
19942.
|
|
|
|
19943.
|
|
|
|
19944.
|
|
|
|
19945.
|
Safety and efficacy of REP 2139 and pegylated interferon alfa-2a for treatment-naive patients with chronic hepatitis B virus and hepatitis D virus co-infection (REP 301 and REP 301-LTF): a non-randomised, open-label, phase 2 trial. [electronic resource] by
- Bazinet, Michel
- Pântea, Victor
- Cebotarescu, Valentin
- Cojuhari, Lilia
- Jimbei, Pavlina
- Albrecht, Jeffrey
- Schmid, Peter
- Le Gal, Frédéric
- Gordien, Emmanuel
- Krawczyk, Adalbert
- Mijočević, Hrvoje
- Karimzadeh, Hadi
- Roggendorf, Michael
- Vaillant, Andrew
Producer: 20180813
In:
The lancet. Gastroenterology & hepatology vol. 2
Availability: No items available.
|
|
|
19946.
|
|
|
|
19947.
|
|
|
|
19948.
|
|
|
|
19949.
|
|
|
|
19950.
|
|
|
|
19951.
|
|
|
|
19952.
|
|
|
|
19953.
|
|
|
|
19954.
|
|
|
|
19955.
|
|
|
|
19956.
|
|
|
|
19957.
|
|
|
|
19958.
|
|
|
|
19959.
|
|
|
|
19960.
|
|